Why this comparison is complicated

Comparing vaping nicotine with smoking cannabis is not a straightforward apples-to-apples assessment. The two involve different substances, different delivery mechanisms, different patterns of use, and different types of health risk. One involves vaporisation with no combustion; the other involves burning plant matter. One delivers a highly addictive stimulant; the other delivers psychoactive and non-psychoactive cannabinoids. To answer the question properly, we need to examine each dimension of harm separately.

The respiratory picture: combustion is the key variable

Smoking cannabis involves full combustion of dried plant material — producing tar, carbon monoxide, benzene, ammonia, and dozens of other harmful byproducts. These are the same toxic compounds found in tobacco smoke, and their effects on the lungs are well documented: chronic bronchitis, increased airway inflammation, and long-term respiratory damage with regular use.

Vaping nicotine, by contrast, involves no combustion at all. E-cigarette vapour is produced by heating a liquid — typically containing propylene glycol, vegetable glycerin, nicotine, and flavourings — to produce an aerosol. Public Health England's landmark assessment concluded that vaping nicotine is significantly less harmful to the respiratory system than smoking tobacco, a finding broadly extended to comparisons with smoked cannabis as well.

On respiratory harm alone, vaping nicotine is considered substantially less damaging than smoking weed.

Mental health: where cannabis carries a distinct risk

One area where smoking cannabis carries risks that vaping nicotine does not is mental health. A substantial body of research has linked regular cannabis use — particularly high-potency cannabis — to an increased risk of anxiety, paranoia, psychosis, and in vulnerable individuals, the onset or worsening of conditions such as schizophrenia.

Nicotine does not carry equivalent psychoactive risks. While nicotine can contribute to anxiety and mood disruption — particularly during withdrawal — it does not alter perception, impair cognition, or carry the same psychiatric risk profile as THC-containing cannabis.

Addiction: nicotine is harder to quit

Nicotine is among the most addictive substances known to science. Physical dependency develops rapidly, and withdrawal symptoms — including intense cravings, irritability, difficulty concentrating, and disrupted sleep — are well established. The NHS considers nicotine addiction one of the hardest habits to break.

Cannabis dependency is real and should not be dismissed, but research consistently places it lower on the addiction severity scale than nicotine. Approximately 9% of cannabis users develop dependency compared to roughly 32% of people who try nicotine. That said, withdrawal from cannabis — including sleep disturbance, irritability, and low mood — can be genuinely difficult for regular users.

Cardiovascular health

Both nicotine and cannabis affect the cardiovascular system, albeit differently. Nicotine raises heart rate and blood pressure, contributes to arterial stiffness, and is associated with increased cardiovascular risk over time — particularly in people with pre-existing heart conditions.

Cannabis also raises heart rate acutely, and there is emerging evidence linking heavy, long-term cannabis use to increased cardiovascular risk. However, the research base on cannabis and cardiovascular health is less mature than for nicotine, partly due to the challenges of conducting large-scale studies in jurisdictions where cannabis has historically been illegal.

Long-term unknowns

An honest assessment of both must acknowledge significant gaps in long-term data. Nicotine vaping has only been widespread for roughly fifteen years, and the full picture of its long-term effects — particularly on the lungs and cardiovascular system — is still emerging. Similarly, research on the long-term effects of cannabis use has historically been constrained by legal barriers, and the shift to higher-potency products in recent years introduces variables that older studies did not account for.

Neither can be declared categorically "safe" — both carry real risks that deserve to be taken seriously.

The legal, lower-risk alternative: CBD vaping

For UK adults curious about the vaping experience or the potential wellness benefits of cannabinoids — without the legal risk of cannabis or the addictive pull of nicotine — hemp-derived CBD vaping offers a compelling middle ground. CBD is non-psychoactive, non-addictive, and when sourced from a reputable, lab-tested UK retailer, free from harmful additives.

At Ace Ultra Premium, the full range of premium hemp vape products is designed for adults who want a quality vaping experience grounded in transparency, safety, and compliance. No nicotine, no THC above legal limits, no unknowns — just clean, full-spectrum hemp oil in a premium portable format.

The bottom line

On balance, the current evidence suggests that vaping nicotine is less harmful to the respiratory system than smoking cannabis — primarily because it eliminates combustion. However, nicotine carries a significantly higher addiction risk, and smoking cannabis carries distinct mental health risks that vaping nicotine does not. Neither is harmless. For UK adults seeking the most responsible choice, legal hemp-derived CBD vaping avoids the key risks of both.

Explore the full collection of lab-tested, nicotine-free hemp vape products at Ace Ultra Premium — the smart choice for quality cannabinoid vaping in the UK.